PETMED EXPRESS, INC. Total Liabilities and Equity
PETMED EXPRESS, INC. (PETS) had Total Liabilities and Equity of $63.76 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $63.76M.
- 2026-03-31: Liabilities and Equity $81.19M.
- 2025-12-31: Liabilities and Equity $87.97M.
- 2025-09-30: Liabilities and Equity $100.30M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $63.76M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $81.19M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $87.97M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $100.30M 10-Q · filed 2025-12-19 | |
| 2025-06-30 | $109.84M 10-Q · filed 2025-12-19 | |
| 2025-03-31 | $148.70M 10-K · filed 2026-06-02 | |
| 2024-12-31 | $144.79M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $146.03M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $152.71M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $169.88M 10-K · filed 2025-10-14 | |
| 2023-12-31 | $173.35M 10-Q · filed 2024-04-15 | |
| 2023-09-30 | $162.70M 10-Q/A · filed 2024-04-15 | $159.27M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $184.28M 10-Q/A · filed 2024-04-15 | $180.74M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $167.48M 10-K · filed 2024-06-14 | $164.12M 10-K · filed 2023-05-23 |
| 2022-12-31 | $169.61M 10-Q · filed 2024-04-15 | $165.12M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $169.26M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $164.74M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $179.70M 10-K/A · filed 2024-04-15 | $176.32M 10-K · filed 2022-05-24 |
| 2021-12-31 | $168.43M 10-Q · filed 2022-02-04 | |
| 2021-09-30 | $159.39M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $173.32M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $187.50M 10-K · filed 2022-05-24 | |
| 2020-12-31 | $167.37M 10-Q · filed 2021-01-26 | |
| 2020-09-30 | $158.95M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $162.75M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $155.32M 10-K · filed 2021-05-25 | |
| 2019-12-31 | $149.54M 10-Q · filed 2020-01-28 | |
| 2019-09-30 | $145.54M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $144.84M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $154.43M 10-K · filed 2020-05-26 | |
| 2018-12-31 | $156.92M 10-Q · filed 2019-01-29 | |
| 2018-09-30 | $148.07M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $152.67M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $134.84M 10-K · filed 2019-05-28 | |
| 2017-12-31 | $135.59M 10-Q · filed 2018-01-30 | |
| 2017-09-30 | $124.88M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $125.67M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $112.81M 10-K · filed 2018-05-29 | |
| 2016-12-31 | $97.62M 10-Q · filed 2017-01-31 | |
| 2016-09-30 | $96.53M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $99.81M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $90.28M 10-K · filed 2017-05-23 | |
| 2015-12-31 | $88.58M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $88.40M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $93.44M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $82.85M 10-K · filed 2016-05-24 | |
| 2014-12-31 | $79.84M 10-Q · filed 2015-01-26 | |
| 2014-09-30 | $79.43M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $86.02M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $78.38M 10-K · filed 2015-05-22 | |
| 2013-12-31 | $75.11M 10-Q · filed 2014-01-31 | |
| 2013-09-30 | $77.83M 10-Q · filed 2013-10-29 | |
| 2013-06-30 | $81.43M 10-Q · filed 2013-07-30 | |
| 2013-03-31 | $73.18M 10-K · filed 2014-05-27 | |
| 2012-12-31 | $70.73M 10-Q · filed 2013-01-29 | |
| 2012-09-30 | $89.36M 10-Q · filed 2012-10-31 | |
| 2012-06-30 | $94.54M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $91.06M 10-K · filed 2013-05-28 | |
| 2011-12-31 | $88.40M 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $87.97M 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $99.42M 10-Q · filed 2011-08-02 | |
| 2011-03-31 | $106.29M 10-K · filed 2012-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |